<DOC>
	<DOCNO>NCT01495156</DOCNO>
	<brief_summary>The propose pilot study placebo-controlled , parallel group , randomize clinical trial compare two treatment strategy adolescent mania prominent psychotic feature . One group receive second generation antipsychotic ( SGA ) placebo receive SGA lithium . The primary double-blind phase study last 8 week , follow 24-week extension-phase .</brief_summary>
	<brief_title>Study Efficacy Adjunctive Lithium Treatment Treatment Psychotic Mania</brief_title>
	<detailed_description />
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Males female , 1218 year old , inpatients outpatient meet DSMIV criterion Bipolar I disorder manic mixed episode psychotic symptom present Exclusion criterion : current serious homicidal/suicidal ideation prior nonresponse intolerance adequate trial lithium prior nonresponse intolerance adequate trial aripiprazole risperidone unstable medical condition medical contraindication treatment lithium , aripiprazole risperidone inability unwillingness discontinue concomitant medication interfere pharmacokinetics either lithium , aripiprazole , risperidone seizure disorder pregnant , sexually active , use birth control , oral contraceptive , two barrier method , longacting depot preparation intrauterine device Full Scale IQ le 70 meet criteria DSMIV diagnosis substanceinduced mood disorder mood disorder due general medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>